Achieve Life Sciences (ACHV) Depreciation and Depletion (2011 - 2017)
Achieve Life Sciences (ACHV) posted Depreciation and Depletion of $37000.0 for Q2 2017, down 60.22% on a QoQ basis from $93000.0 in Q1 2017, and down 21.28% year-over-year from $47000.0 in Q2 2016.
Achieve Life Sciences (ACHV) Depreciation and Depletion (2011 - 2017) Analysis & Trends
Achieve Life Sciences' Depreciation and Depletion history runs 7 years deep, the most recent figure standing at $37000.0 for Q2 2017.
- Quarterly Depreciation and Depletion fell 21.28% year-over-year to $37000.0 in Q2 2017, while the trailing twelve-month figure through Jun 2017 was $215000.0 (down 6.93% YoY) and the FY2021 annual result came in at $27000.0, down 15.62% from the prior year.
- Depreciation and Depletion was $37000.0 for Q2 2017 at Achieve Life Sciences, down from $93000.0 in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $93000.0 in Q1 2017 and bottomed at $37000.0 in Q2 2017.
- A 5-year average of $56222.2 and a median of $55500.0 in 2013 frame the typical range for Depreciation and Depletion.
- Annual changes were most pronounced in 2013 — Depreciation and Depletion soared 133.33% — and 2016, when it plunged 39.39%.
- Achieve Life Sciences' Depreciation and Depletion stood at $65000.0 in 2013, then decreased by 10.77% to $58000.0 in 2014, then increased by 13.79% to $66000.0 in 2015, then plunged by 39.39% to $40000.0 in 2016, then retreated by 7.5% to $37000.0 in 2017.
- Business Quant data shows ACHV's Depreciation and Depletion at $37000.0 in Q2 2017, $93000.0 in Q1 2017, and $40000.0 in Q4 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 39.39 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Achieve Life Sciences | 2.54 Mn | 2.54 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | 37,000.00 |
| Jun 30, 2017 | 37,000.00 |
| Mar 31, 2017 | 93,000.00 |
| Mar 31, 2017 | 93,000.00 |
| Dec 31, 2016 | 40,000.00 |
| Dec 31, 2016 | 40,000.00 |
| Sep 30, 2016 | 45,000.00 |
| Sep 30, 2016 | 45,000.00 |
| Jun 30, 2016 | 47,000.00 |
| Jun 30, 2016 | 47,000.00 |
| Mar 31, 2016 | 56,000.00 |
| Mar 31, 2016 | 56,000.00 |
| Dec 31, 2015 | 66,000.00 |
| Dec 31, 2015 | 66,000.00 |
| Sep 30, 2015 | 62,000.00 |
| Sep 30, 2015 | 62,000.00 |
| Jun 30, 2015 | 70,000.00 |
| Jun 30, 2015 | 70,000.00 |
| Mar 31, 2015 | 46,000.00 |
| Mar 31, 2015 | 46,000.00 |